PATENT CLAIM ANALYSIS

Application Number: 15900677
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "649000"]

Abstract:
Provided herein are methods of treating cancer in a subject by administering COH29 ((N-(4-(3,4-diydroxyphenyl)-5-phenylthiazol-2-yl)-3,4-dihydroxybenzamide)). The methods of treating include treating a BRCA1-defective subject, a PARP1 inhibitor-resistant subject or a DNA-damaging anti-cancer agent resistant subject. The methods include treating cancer by administering COH29 and a DNA-damaging anti-cancer agent in a combined synergistic amount.

Claim (Index 1):
A method of treating cancer in a subject in need thereof, said method comprising administering an effective amount of a compound having the structure: wherein said subject is a BRCA1-defective subject, a PARP1 inhibitor-resistant subject or a DNA-damaging anti-cancer agent resistant subject.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 88.0
- Lexical Diversity: 1.88889
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15242249', '15514928', '14772549', '15746806', '13679756']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6869366551783361
- 35 USC 102 Novelty (BERT): 0.6092483141211906
- Combined Prediction Score: 0.6791678210726215
- Mean Citation Score: 343.645462
- Max Citation Score: 541.0218
- Similarity Product: 479.5460105685354

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test